CPRX
Undervalued by 11.1% based on the discounted cash flow analysis.
Market cap | $1.81 Billion |
---|---|
Enterprise Value | $1.67 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.63 |
Beta | 1.23 |
Outstanding Shares | 118,011,092 |
Avg 30 Day Volume | 1,079,319 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 25.35 |
---|---|
PEG | 68.89 |
Price to Sales | 5.04 |
Price to Book Ratio | 5.04 |
Enterprise Value to Revenue | 4.2 |
Enterprise Value to EBIT | 19.27 |
Enterprise Value to Net Income | 23 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data